Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	802	406	108	125	256	297
Market Cap Growth	104.69%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	750	377	85	117	226	284
Last Close Price	10.16	5.30	1.43	1.68	3.74	4.80
PE Ratio	56.80	47.50	-	-	-	-
Forward PE	93.86	50.28	-	-	-	-
PS Ratio	7.21	4.08	1.29	1.74	3.79	5.02
PB Ratio	14.44	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	14.58	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	41.06	33.99	15.45	-	-	-
P/OCF Ratio	40.74	33.54	15.13	-	-	-
EV/Sales Ratio	6.95	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	53.52	44.12	-	-	-	-
EV/EBIT Ratio	56.73	48.76	-	-	-	-
EV/FCF Ratio	38.40	31.54	12.17	-	-	-
Debt / Equity Ratio	0.06	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.23	0.27	-	-	-	-
Debt / FCF Ratio	0.18	0.22	0.47	-	-	-
Asset Turnover	1.59	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.42	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.04	2.96	1.57	1.61	1.89	1.17
Current Ratio	3.66	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	33.47%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	12.21%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	18.16%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	21.90%	15.40%	-	-	-	-
Earnings Yield	1.76%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	2.44%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-6.70%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.